Shifts in Prescription Drug Pricing and Global Economic Momentum

This chapter dives into the latest news on initiatives aimed at reducing prescription drug costs in the U.S., specifically for obesity medications from major pharmaceutical firms. It also reviews past efforts at drug price regulation and sets the stage for insights from the upcoming State of the Union address, focusing on global economic shifts and emerging market trends.